此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

扩大肯尼亚严重急性营养不良 (SAM) 治疗的覆盖范围 (R-SWITCH)

评估授权社区健康促进者通过家庭主导的 MUAC 扩大、年龄体重筛查和违约者随访来提高图尔卡纳县消瘦治疗覆盖率的影响、实施和成本

Child wasting is a type of malnutrition which occurs when a child becomes too thin. This medical condition increases the risk of becoming sick or dying. A child with severe wasting needs to be seen in a medical consultation to check on health status and to receive some medicine and a medical food supplement for daily consumption until cured. Yet, only a small proportion of children suffering from severe wasting are presently receiving appropriate treatment.

In Kenya, there is an opportunity to build on the existing network of community health promoters (CHPs) to increase the number of children with wasting who are identified and treated. In intervention areas, CHPs will be equipped with smartphones and an application which provides guidance on household members to visit and simple actions to take, related to health. CHPs will distribute color-coded mid-upper arm circumference tapes to households with young children and train caregivers on how to use it. After training, CHPs will send Short Message Services (SMS) to remind caregivers to regularly measure the arm circumference of the child. In addition, CHPs will receive a scale to measure the weight of children every month. Finally, wasted children registered in the treatment program who fail to attend a planned consultation will be flagged to their CHP through the phone application, and CHPs will conduct a specific home visit to investigate and help solve potential issues.

The study will assess whether this community intervention (called SWITCH) allows to identify and treat more children suffering from severe wasting. Before the start of the intervention, the proportion of wasted children receiving treatment in 40 community units in Turkana South, Turkana East and Aroo will be assessed. After this survey, a computer will randomly select 20 community units where the intervention will be scaled up. The survey will be repeated after 2 years to assess if the proportion of severely wasted children receiving treatment is higher in the area where the intervention was scaled up compared to the area where it was not scaled up.

In addition, after 1 year of implementation, the study will assess how the intervention was scaled up, what are the main challenges, and what are the overall perceptions on the intervention in the community among those who receive it and those who deliver it. Finally, costs of the various components of the intervention will be measured for all actors involved, including for caregivers.

研究概览

详细说明

Despite the burden and impact of child wasting on morbidity and mortality, only a small proportion of severely wasted children are presently receiving treatment. In Kenya, there is an opportunity to strengthen the screening for wasting and the identification and treatment of wasted children (SWITCH) through community health promoters (CHPs) who, per policy, are trained, equipped, incentivized and supervised by community health agents (CHAs).

An intervention package will be implemented including: 1) Digitization to support CHPs, 2) Family-led Mid-Upper Arm Circumference (MUAC) enhanced by digitization, with a two-way messaging platform between CHP and caregivers, and reminders for timely training at 6 months of age, 3) Equipment of CHPs with a baby-mother scale for measurement of weight-for-age to detect likely wasting, and 4) Real-time follow-up in the community (facilitated by digitization) of defaulters and non-respondent children enrolled for wasting treatment.

A randomized controlled trial will be used to assess the impact of the SWITCH intervention on severe wasting treatment coverage in Turkana. Twenty randomly selected community units of 40 will receive the intervention. An exhaustive screening campaign conducted at baseline and endline (after 2 years) in the 40 community units will identify children with severe wasting (MUAC < 115 mm or Weight-for-Height Z-score < -3 or bilateral pitting oedema) or recovering from severe wasting (defined by receipt and consumption of Ready-to-Use Therapeutic Food), who will be enrolled in a survey assessing treatment coverage, program exposure and other pathways to impact, and confounders.

In addition, the study will assess the reach, adoption by CHPs, and implementation challenges of the SWITCH package through additional qualitative (interviews and observations) and quantitative data collection at all levels of program delivery (beneficiaries, CHPs, CHAs, program implementers); and the unit cost of the SWITCH package per beneficiary (and cost-effectiveness if the package is effective) through an activity-based costing-ingredients approach.

研究类型

介入性

注册 (实际的)

31504

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Lodwar、肯尼亚
        • Turkana South and Turkana East and Aroo

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

6个月 至 5年 (孩子)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Household in a village of the study area covered by a CHP (although the child may or may not be registered by a CHP) AND

  • Child is 6-59.9 months of age AND

  • Caregiver consents to be part of the study AND

  • any of the following:

    • WHZ < -3 (relative to WHO 2006 reference) OR
    • MUAC <115 mm OR
    • Presence of bilateral edema OR
    • receiving treatment as follow-up for an initial SAM condition on the way to full recovery

exclusion criteria is:

  • Congenital malformation that makes anthropometric measurements impossible.
  • Length is below 54 cm or height is above 120cm.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Standard of Care
  • Register-based household registration (census) by CHP every 12 months
  • Some family MUAC of variable and unknown coverage/frequency, national guidance developed.
  • Some passive screening using weight-for-height z-score at Health Facility and during outreach during Malezi bora (child health week every 6 months).
  • Monthly compilation by CHA (supervisors) of the list of defaulters and non-respondents for transmission to relevant community health promoter (CHP) during monthly in-person meeting.
实验性的:SWITCH intervention package
  • Addition of digital monitoring & supervision by CHA
  • Digitized registration of households by CHPs every 6 months
  • Digital reminders to CHP to conduct home visit if a child has never been visited in 3 mo.
  • Digital reminder for timely training to family MUAC of all family members through home visit by CHP when child turns 6 months of age.
  • Platform for 2-ways messaging: biweekly SMS reminders to caregivers through the CHP's app; feedback by caregiver
  • Community level screening based on weight and weight-for-age (WAZ) led by CHP every other month (aligned with Community Action Days),
  • Digital calculation of WAZ.
  • CHP and Growth Monitoring and Promotion refer to health facility if WAZ<-3 to check on WHZ eligibility
  • At the end of every wasting treatment consultation, compilation of the list of defaulters and non-respondents, for immediate transmission by CHA to relevant CHP through digital task of an instruction for immediate follow-up.
  • Addition of digital monitoring & supervision by CHA
  • Digitized registration of households by CHPs every 6 months
  • Digital reminders to CHP to conduct home visit if a child has never been visited in 3 mo.
  • Digital reminder for timely training to family MUAC of all family members through home visit by CHP when child turns 6 months of age.
  • Platform for 2-ways messaging: biweekly SMS reminders to caregivers through the CHP's app; feedback by caregiver
  • Community level screening based on weight and weight-for-age (WAZ) led by CHP every other month (aligned with Community Action Days),
  • Digital calculation of WAZ.
  • CHP and Growth Monitoring and Promotion refer to health facility if WAZ<-3 to check on WHZ eligibility
  • At the end of every wasting treatment consultation, compilation of the list of defaulters and non-respondents, for immediate transmission by CHA to relevant CHP through digital task of an instruction for immediate follow-up.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Period prevalence of severe wasting (SAM) treatment coverage in children 6-59 months of age
大体时间:After 24 months of program implementation

defined as the proportion of children suffering from SAM or recovering from SAM who currently receive treatment.

• SAM defined by weight-for-height Z-score (WHZ) <-3 (relative to World Health Organization (WHO) 2006 reference) or MUAC <115 mm or by the presence of bilateral edema.

Children recovering from SAM through treatment will be considered to receive treatment for an initial SAM condition if they both attended an IMAM consultation in the previous 15 days (as reported by caregiver OR by a consultation card) AND either:

  • consumed RUTF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation of >= 1 full or 2 empty RUTF sachets) OR
  • consumed RUSF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation by the enumerator of >= 1 full or 2 empty RUSF sachets) AND child was previously enrolled for SAM treatment immediately prior to MAM treatment (as confirmed by treatment card OR reported by the mother
After 24 months of program implementation

次要结果测量

结果测量
措施说明
大体时间
Mean weight-for-height Z-score (WHZ)
大体时间:After 24 months of program implementation

In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Mean mid-upper arm circumference (MUAC)
大体时间:After 24 months of program implementation

In 6-59 months old children.

After 24 months of program implementation
Point prevalence of SAM outpatient therapeutic program (OTP) treatment coverage in children 6-59 months of age
大体时间:After 24 months of program implementation

Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome)

After 24 months of program implementation
Screening coverage of SAM
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months suffering from SAM ((currently or on their way to recovery from SAM through treatment for an initial SAM condition) ) screened for wasting over the last 30 days (as reported by the caregiver)

After 24 months of program implementation
Prevalence of SAM
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 (relative to World Health Organization (WHO) 2006 reference) or a MUAC < 115 mm or the presence of bilateral pitting edema). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome)

After 24 months of program implementation
Prevalence of very low WHZ
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with WHZ <-3 (relative to World Health Organization (WHO) 2006 reference).

After 24 months of program implementation
Prevalence of very low MUAC
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with MUAC<115 mm

After 24 months of program implementation
Prevalence of moderate acute malnutrition (MAM)
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with MAM (defined as -3<= WHZ <-2 (relative to World Health Organization (WHO) 2006 reference) or 115<= MUAC < 125 mm). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome)

After 24 months of program implementation
Prevalence of wasting
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 (relative to World Health Organization (WHO) 2006 reference) or a MUAC < 125 mm or the presence of bilateral pitting edema). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome)

After 24 months of program implementation
Prevalence of stunting
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months suffering from SAM or recovering from SAM with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Prevalence of underweight and severe underweight
大体时间:After 24 months of program implementation

Defined as the proportion of children aged 6-59 months suffering from SAM or recovering from SAM with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Mean height-for-age Z-score (HAZ)
大体时间:After 24 months of program implementation

In 6-59 months old children suffering from SAM or recovering from SAM. Scores will be calculated relative to World Health Organization (WHO) 2006 reference, with a higher score meaning a better outcome

After 24 months of program implementation
Mean weight-for-age Z-score (WAZ)
大体时间:After 24 months of program implementation

In 6-59 months old children suffering from SAM or recovering from SAM. To calculate WAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Caregiver's knowledge score
大体时间:After 24 months of program implementation

The score will be calculated by adding one point for each right answer to a series of questions related to infant and child feeding, child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting. Questions were specifically developed for the study based on program activities and asked to caregiver of children aged 6-59 months suffering from SAM or recovering from SAM

After 24 months of program implementation
Prevalence of appropriate immunization
大体时间:After 24 months of program implementation

Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all recommended immunizations

After 24 months of program implementation
Coverage of the integrated management of acute malnutrition (IMAM) platform
大体时间:After 24 months of program implementation

proportion of children aged 6-59 months suffering from SAM or recovering from SAM who attended an IMAM consultation in the previous 15 days (as reported by the caregiver or by an IMAM treatment card)

After 24 months of program implementation
Coverage of the community unit platform
大体时间:After 24 months of program implementation

proportion of children aged 6-59 months suffering from SAM or recovering from SAM in contact with a CHP in the 2 months preceding the survey for community care-related matter (as reported by the caregiver)

After 24 months of program implementation
Coverage of family MUAC
大体时间:After 24 months of program implementation

proportion of children aged 6-59 months suffering from SAM or recovering from SAM screened in the month preceding the survey by a family member using a MUAC tape (as reported by the caregiver)

After 24 months of program implementation
Coverage of family MUAC training
大体时间:After 24 months of program implementation

proportion of children aged 6-59 months suffering from SAM or recovering from SAM for which at least one family member was trained to use MUAC tape (as reported by the caregiver)

After 24 months of program implementation
Coverage of MUAC tapes
大体时间:After 24 months of program implementation

proportion of children aged 6-59 months suffering from SAM or recovering from SAM for which at least one family member owns a MUAC tape (as reported by the caregiver AND confirmed by observation)

After 24 months of program implementation
Coverage of WAZ screening
大体时间:After 24 months of program implementation

proportion of children aged 6-59 months suffering from SAM or recovering from SAM weighed in the 2 months preceding the survey by a CHP or a health staff using a scale (as reported by the caregiver)

After 24 months of program implementation
Period prevalence of wasting treatment coverage in children 6-59 months of age
大体时间:After 24 months of program implementation

Defined as the proportion of children suffering or recovering from wasting who currently receive treatment.

• Wasting defined by weight-for-height Z-score (WHZ) <-2 (relative to World Health Organization (WHO) 2006 reference) or MUAC <125 mm or by the presence of bilateral edema.

Children recovering from wasting will be considered to receive treatment if they both attended an IMAM consultation in the previous 15 days (as reported by caregiver OR by a consultation card) AND either:

consumed RUTF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation of >= 1 full or 2 empty RUTF sachets) OR consumed RUSF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation by the enumerator of >= 1 full or 2 empty RUSF sachets) AND child does not suffer from SAM (as defined above)

After 24 months of program implementation

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Elodie Becquey, PhD、International Food Policy Research Institute
  • 首席研究员:Sophie Ochola, PhD、Kenyatta University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年6月3日

初级完成 (实际的)

2026年7月30日

研究完成 (实际的)

2026年7月30日

研究注册日期

首次提交

2024年5月6日

首先提交符合 QC 标准的

2024年5月28日

首次发布 (实际的)

2024年6月4日

研究记录更新

最后更新发布 (实际的)

2026年11月12日

上次提交的符合 QC 标准的更新

2026年11月9日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

All data will be carefully anonymized and de-identified so that the privacy of participants and research subjects is fully protected. Databases will be anonymized using identification codes. No names, GPS coordinates, dates of birth or other identifying data will be stored in the databases.

At the time of publication of scientific articles presenting primary results, the fully anonymized databases (quantitative data) will become a public good and will be made available to the scientific community, government, and partners.

IPD 共享时间框架

At the time of publication of scientific articles presenting primary results.

IPD 共享支持信息类型

  • 研究方案
  • 树液

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅